NOVOLOG
NDC 0169-2101, insulin aspart, injection, solution, from Novo Nordisk.
- Product NDC
- 0169-2101
- Status
- Listed
- Labeler
- Novo Nordisk
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA020986
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN ASPART100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-2101-25 | 00169210125 | 5 SYRINGE, PLASTIC in 1 CARTON (0169-2101-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-2101-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3a1e73a2-3009-40d0-876c-b4cb2be56fc5Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0169-2101
Use it
Look up 0169-2101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-2101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.